All Stories

  1. Beyond ORBIT: Mapping the Constellation of Pseudomonas Endotypes in Bronchiectasis Clinical Trials
  2. Ever tried. Ever failed. No matter. The CFMATTERS study and the future of microbiome-directed trials in cystic fibrosis
  3. Accelerated Lung Function Decline and Mucus–Microbe Evolution in Chronic Obstructive Pulmonary Disease
  4. Unsung Heroes? Decoding the Protective Effects of Airway Microbiota in Chronic Obstructive Pulmonary Disease
  5. Airway “Resistotypes” and Clinical Outcomes in Bronchiectasis
  6. Infection and the microbiome in bronchiectasis
  7. Targeting respiratory microbiomes in COPD and bronchiectasis
  8. Reply to Ward et al.
  9. Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis
  10. Bronchiectasis
  11. Aspergillus-Associated Endophenotypes in Bronchiectasis
  12. Similarity network fusion (SNF) for the integration of multi-omics and microbiomes in respiratory disease
  13. On Bugs and Blowholes: Why Is Aspiration the Rule, Not the Exception?
  14. Integrative microbiomics in bronchiectasis exacerbations
  15. Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease
  16. Increased Chitotriosidase Is Associated With Aspergillus and Frequent Exacerbations in South-East Asian Patients With Bronchiectasis
  17. “High-Risk” Clinical and Inflammatory Clusters in COPD of Chinese Descent
  18. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
  19. Whole-Genome Sequencing of Aspergillus terreus Species Complex
  20. Reply to: Bacterial DNA in Fetal Lung Samples May Be Explained by Sample Contamination
  21. The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
  22. Airway microbiome composition correlates with lung function and arterial stiffness in an age-dependent manner
  23. Optimisation and Benchmarking of Targeted Amplicon Sequencing for Mycobiome Analysis of Respiratory Specimens
  24. MycopathologiaGENOMES: The New ‘Home’ for the Publication of Fungal Genomes
  25. Bronchiectasis and cough: An old relationship in need of renewed attention
  26. Distinct “Immunoallertypes” of Disease and High Frequencies of Sensitization in Non–Cystic Fibrosis Bronchiectasis
  27. Intercontinental translocation of latent multidrug‐resistant tuberculosis to Australia demonstrated by whole genome sequencing
  28. Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives
  29. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study
  30. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014–2016: focus on extended-spectrum cephalosporins and azithromycin
  31. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
  32. Field of genes: using Apache Kafka as a bioinformatic data repository
  33. The Microbial Endocrinology of Pseudomonas aeruginosa: Inflammatory and Immune Perspectives
  34. Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case
  35. Draft Genome Sequence of the First Confirmed Isolate of Multidrug-Resistant Mycobacterium tuberculosis in Tasmania
  36. Fourteen Draft Genome Sequences for the First Reported Cases of Azithromycin-Resistant Neisseria gonorrhoeae in Ireland
  37. Differential carriage of virulence-associated loci in the New Zealand Rangipo outbreak strain of Mycobacterium tuberculosis
  38. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD
  39. Understanding COPD-overlap syndromes
  40. Microbiomes in respiratory health and disease: An Asia-Pacific perspective
  41. Draft Genome Sequence of a New Zealand Rangipo Strain of Mycobacterium tuberculosis
  42. Possible Interplay Between Hospital and Community Transmission of a Novel Clostridium Difficile Sequence Type 295 Recognized by Next-Generation Sequencing
  43. Characterization of Escherichia coli bloodstream isolates associated with mortality
  44. Identification of emergent blaCMY-2-carrying Proteus mirabilis lineages by whole-genome sequencing
  45. A first glance at the genome of Mycobacterium chimeara - a pathogen of renewed clinical importance
  46. Identification of a novel mutation at the primary dimer interface of GyrA conferring fluoroquinolone resistance in Clostridium difficile
  47. Typhlocolitis associated with Clostridium difficile ribotypes 078 and 110 in neonatal piglets from a commercial Irish pig herd
  48. Enhanced Tracking of Nosocomial Transmission of Endemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Type IV Isolates among Patients and Environmental Sites by Use of Whole-Genome Sequencing
  49. Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection
  50. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections
  51. Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3
  52. Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland: Table 1.
  53. Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3
  54. Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland
  55. Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand
  56. The non-classical ArsR-family repressor PyeR (PA4354) modulates biofilm formation in Pseudomonas aeruginosa
  57. Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey
  58. MexT Functions as a Redox-Responsive Regulator Modulating Disulfide Stress Resistance in Pseudomonas aeruginosa
  59. Emergence of extended-spectrum β-lactamase and fluoroquinolone resistance genes among Irish multidrug-resistant isolates
  60. Transcriptome profiling defines a novel regulon modulated by the LysR-type transcriptional regulator MexT in Pseudomonas aeruginosa
  61. MexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pump